Identiification of novel biomarkers and therapeutic targets for the treatment of pancreatic cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1106291

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Pancreatic cancer is a devastating disease with an appalling prognosis - only 6% of patient survive 5 years after diagnosis. The aim of this research is to use new technologies to find out how pancreatic cells become malignant and why the cancerous cells are so drug resistant. The goal is to ideantify cell markers to guide drug treatment design and new targets for antibody therapy. By combining emerging technologies we hope to achieve break-through outcomes in the treatment of pancreatic cancer.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2020

Funding Scheme: Early Career Fellowships

Funding Amount: $362,463.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Cell Biology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer biology | cell death | chemotherapy | mouse models | therapeutic agents

Related Links